NeoGenomics Inc
NEO• NASDAQ
$8.96
-0.06-0.67%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Revenue
$186.67M
Net income
-$17.11M
Free cash flow
-$13.14M
Diluted EPS
—
Gross margin
43.32%
Profit margin
-9.16%
Assets
$1.35B
Cash
$146.14M
Valuation
Market Cap$1.17B
Enterprise Value$1.37B
PE (TTM)—
PE (Fwd)222.22
Price to Sales1.61
EV / EBITDA-27.92
Price to Book0.28
PEG Ratio2.09
Cash Flow
FCF Yield-0.43%
FCF / Share-$0.20
SBC-Adj FCF Yield-3.86%
SBC-Adj FCF / Share-$1.75
SBC Impact+790.05%
Margins & Growth
Gross Margin38.85%
Operating Margin-9.09%
Profit Margin-13.30%
Quarterly Rev YoY+11.09%
Quarterly EPS YoY+34.01%
Balance
Cash$146.14M
Debt$346.69M
Net Debt$200.54M
Current Ratio4.42
Debt / Equity41.83
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
Trailing 12 months
$0.00
Latest dividend
$0.40 · Dec 17, 2020
First record
Dec 17, 2020
Next ex-date
—
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Dec 17, 2020 | $0.40 | Dec 30, 2020 | — |
Price
-79.44%
Jun 14, 2021 - Apr 29, 2026 · 1,225 daily points
Revenue
↑ 114.6%Net Income
↓ 150.7%Free Cash Flow
↓ 317.8%Diluted EPS
No data
Quick Stats
Open
$10.23
Day High
$10.33
Day Low
$8.18
Prev Close
$9.02
Market Cap
—
Volume
10,704,831
NeoGenomics Inc (NEO) analysis
Wrqti brings NeoGenomics Inc data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$8.96
Market cap
$1.17B
PE ratio
—
Price to book
0.28
Profit margin
-13.30%
FCF yield
-0.43%
Stocks related to NeoGenomics Inc
Companies in the same sector you can compare with NeoGenomics Inc: